These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10378694)

  • 1. The role of c-myc in cellular growth control.
    Schmidt EV
    Oncogene; 1999 May; 18(19):2988-96. PubMed ID: 10378694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of c-myc in regulation of translation initiation.
    Schmidt EV
    Oncogene; 2004 Apr; 23(18):3217-21. PubMed ID: 15094771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WI-38 cell long-term quiescence model system: a valuable tool to study molecular events that regulate growth.
    Soprano KJ
    J Cell Biochem; 1994 Apr; 54(4):405-14. PubMed ID: 8014189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proto-oncogene c-myc in hematopoietic development and leukemogenesis.
    Hoffman B; Amanullah A; Shafarenko M; Liebermann DA
    Oncogene; 2002 May; 21(21):3414-21. PubMed ID: 12032779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocations involving c-myc and c-myc function.
    Boxer LM; Dang CV
    Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
    Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
    Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alpha1 subunit of GABAA receptor is repressed by c-myc and is pro-apoptotic.
    Vaknin UA; Hann SR
    J Cell Biochem; 2006 Apr; 97(5):1094-103. PubMed ID: 16294320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated control of cell proliferation and cell death by the c-myc oncogene.
    Evan G; Harrington E; Fanidi A; Land H; Amati B; Bennett M
    Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):269-75. PubMed ID: 7846125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line.
    Schlosser I; Hölzel M; Hoffmann R; Burtscher H; Kohlhuber F; Schuhmacher M; Chapman R; Weidle UH; Eick D
    Oncogene; 2005 Jan; 24(3):520-4. PubMed ID: 15516975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
    Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
    Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p27kip1-independent cell cycle regulation by MYC.
    Berns K; Martins C; Dannenberg JH; Berns A; te Riele H; Bernards R
    Oncogene; 2000 Oct; 19(42):4822-7. PubMed ID: 11039898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Myc oncoprotein as a therapeutic target for human cancer.
    Vita M; Henriksson M
    Semin Cancer Biol; 2006 Aug; 16(4):318-30. PubMed ID: 16934487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression.
    Habel ME; Lemieux R; Jung D
    J Cell Physiol; 2005 Apr; 203(1):277-85. PubMed ID: 15468060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The c-Myc target gene network.
    Dang CV; O'Donnell KA; Zeller KI; Nguyen T; Osthus RC; Li F
    Semin Cancer Biol; 2006 Aug; 16(4):253-64. PubMed ID: 16904903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of Myc1 and Myc2 isoforms in cells transformed by eIF4E: evidence for internal ribosome repositioning in the human c-myc 5'UTR.
    Carter PS; Jarquin-Pardo M; De Benedetti A
    Oncogene; 1999 Jul; 18(30):4326-35. PubMed ID: 10439040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementation of Myc-dependent cell proliferation by cDNA expression library screening.
    Nikiforov MA; Kotenko I; Petrenko O; Beavis A; Valenick L; Lemischka I; Cole MD
    Oncogene; 2000 Oct; 19(42):4828-31. PubMed ID: 11039899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis.
    Lawlor ER; Soucek L; Brown-Swigart L; Shchors K; Bialucha CU; Evan GI
    Cancer Res; 2006 May; 66(9):4591-601. PubMed ID: 16651409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.